Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Spinal cord repair and rehabilitation

Loss of RhoA in microglia disables glycolytic adaptation and impairs spinal cord injury recovery through Arhgap25/HIF-1α pathway.

Jiale Cai; Xinya Zheng; Xiongbo Luo; Wenli Cui; Xinrui Ma; Shuyi Xu; Lanya Fu; Jiaqi Zhang; Yizhou Xu; Yunlun Li; Ye He; Xianghai Wang; Jiasong Guo

Originally published in Cell death & disease · 2025-08-22

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

RhoA, a small GTPase, plays a pivotal role in various diseases, including spinal cord injury (SCI). Although RhoA inhibition has been traditionally viewed as beneficial for SCI repair, recent clinical trials of RhoA inhibitors in SCI have failed to show significant therapeutic efficacy, suggesting functional heterogeneity across different cell types. The role of RhoA in microglia, the key immune cells involve in SCI, remains poorly understood. Using microglial RhoA conditional knockout mice, this study demonstrated that RhoA deficiency in microglia attenuates the morphological and functional repair of the SCI mice, and impairs the microglial biofunctions of proliferation, phagocytosis, and migration. Single-cell RNA sequencing, bulk RNA sequencing, and metabolomics revealed that RhoA deficiency can attenuate the microglial glycolytic enzyme expression, ATP production, ECAR and OCR levels through the Arhgap25/HIF-1α pathway.

Discussion

Research on SCI has spanned several decades, yielding numerous exciting breakthroughs. In particular, recent advancements in brain-spinal interface [34–36] and epidural electrical stimulation [37–39] have shown significant clinical efficacy. However, it is regrettable that despite extensive studies aimed at improving the microenvironment or the neuronal intrinsic regenerative capability to promote SCI repair, successful clinical applications remain rare [12, 13, 40]. This underscores the inherent complexity of SCI pathophysiology.

Conclusion

In summary, this is the first study to reveal that the SCI resulted RhoA upregulation in microglia plays positive roles in SCI repair which may due to RhoA regulating microglial bio-functions of proliferation, migration and phagocytosis through the Arhgap25/HIF-1α pathway mediated modulating glycolysis.

Editorial reading guide

  • How did the authors define recovery, and when did they measure it?
  • Does the outcome reflect a laboratory measure, a functional change or participation in daily life?